Page 331 - Read Online

Monks et al. J Cancer Metastasis Treat 2019;5:24 I http://dx.doi.org/10.20517/2394-4722.2018.79 Page 17 of 23

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56.
2. Takemura Y, Ouchi N, Shibata R, Aprahamian T, Kirber MT, et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-
dependent clearance of early apoptotic bodies. J Clin Invest 2007;117:375-86.
3. van Stijn CM, Kim J, Barish GD, Tietge UJ, Tangirala RK. Adiponectin expression protects against angiotensin II-mediated inflammation
and accelerated atherosclerosis. PLoS One 2014;9:e86404.
4. Yamauchi T, Kamon J, Ito Y, TsuchLabela A, Yokomizo T, et al. Cloning of adiponectin receptors that mediate antLabeliabetic metabolic
effects. Nature 2003;423:762-9.
5. Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30.
Nat Med 2002;8:731-7.
6. Khandekar MJ, Cohen P, Spiegelman BM. Molecular mechanisms of cancer development in obesity. Nat Rev Cancer 2011;11:886-95.
7. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J
Biol Chem 1995;270:26746-9.
8. Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Curr
Biol 1998;8:335-40.
9. Wang Y, Lam KSL, Yau M, Xu A. Post-translational modifications of adiponectin: mechanisms and functional implications. Biochem J
2008;409:623-33.
10. Fujimoto N, Matsuo N, Sumiyoshi H, Yamaguchi K, Saikawa T, et al. Adiponectin is expressed in the brown adipose tissue and surrounding
immature tissues in mouse embryos. Biochim Biophys Acta - Gene Struct Expr 2005;1731:1-12.
11. Kusminski CM, McTernan PG, Schraw T, Kos K, O’Hare JP, et al. Adiponectin complexes in human cerebrospinal fluid: distinct complex
distribution from serum. Diabetologia 2007;50:634-42.
12. Piñeiro R, Iglesias MJ, Gallego R, Raghay K, Eiras S, et al. Adiponectin is synthesized and secreted by human and murine cardiomyocytes.
FEBS Lett 2005;579:5163-9.
13. Delaigle AM, Jonas JC, Bauche IB, Cornu O, Brichard SM. Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo
and in vitro studies. Endocrinology 2004;145:5589-97.
14. Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 2005;54:117-21.
15. Yokota T, Meka CS, Medina KL, Igarashi H, Comp PC, et al. Paracrine regulation of fat cell formation in bone marrow cultures via
adiponectin and prostaglandins. J Clin Invest 2002;109:1303-10.
16. Suzuki S, Wilson-Kubalek EM, Wert D, Tsao TS, Lee DH. The oligomeric structure of high molecular weight adiponectin. FEBS Lett NIH
Public Access2007;581:809-14.
17. Katira A, Tan PH. Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity.
Expert Opin Ther Targets 2015;19:1105-25.
18. Shibata R, Sato K, Pimentel DR, Takemura Y, Kihara S, et al. Adiponectin protects against myocardial ischemia-reperfusion injury through
AMPK- and COX-2-dependent mechanisms. Nat Med 2005;11:1096-103.
19. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.
Nature 2003;423:762-9.
20. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of
adiponectin binding and metabolic actions. Nat Med 2007;13:332-9.
21. Hebbard LW, Garlatti M, Young LJT, Cardiff RD, Oshima RG, et al. T-cadherin supports angiogenesis and adiponectin association with the
vasculature in a mouse mammary tumor model. Cancer Res 2008;68:1407-16.
22. Brochu-Gaudreau K, Rehfeldt C, Blouin R, Bordignon V, Murphy BD, et al. Adiponectin action from head to toe. Endocrine 2010;37:11-32.
23. Hug C, Wang J, Ahmad NS, Bogan JS, Tsao TS, et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/
adiponectin. Proc Natl Acad Sci 2004;101:10308-13.
24. Xu XT, Xu Q, Tong JL, Zhu MM, Huang ML, et al. Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma.
J Dig Dis 2011;12:234-44.
25. Joshi RK, Kim WJ, Lee SA. Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis.
World J Gastroenterol 2014;20:7941.
26. An W, Bai Y, Deng SX, Gao J, Ben QW, et al. Adiponectin levels in patients with colorectal cancer and adenoma. Eur J Cancer Prev
2012;21:126-33.
27. Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a
prospective study. J Natl Cancer Inst 2005;97:1688-94.
28. Song M, Zhang X, Wu K, Ogino S, Fuchs CS, et al. Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a
prospective study. Cancer Prev Res (Phila) 2013;6:875-85.
29. Ferroni P, Palmirotta R, Spila A, Martini F, Raparelli V, et al. Prognostic significance of adiponectin levels in non-metastatic colorectal
cancer. Anticancer Res 2007;27:483-9.